DELFI Diagnostics’ Post

Hear the latest from thought leaders in cell & gene therapy.

At Eppendorf, we believe in the power of data. Now more than ever, it's crucial to test multiple cell culture growth parameters with efficiency and precision. Especially when it comes to cell and gene therapy research, being able to yield rock-solid datasets is key to keep your process-development rolling. 📈 With our software solutions, we help you control, understand, and optimize bioprocess results by enabling real-time process monitoring and rapid course corrections. But we don’t stop there – we're with you every step of the way!🚀💡 So come and talk to us, we're all ears. Let’s bioprocess together. 🙌🏼 Find out more: https://lnkd.in/ea9R7DgS #bioprocess #data #customercentricity #letsbioprocesstogether

Check out the latest edition of the Eurofins BioPharm News and learn all about what is going on here! You may just see some of our favorite human factors colleagues featured! :-) #eurofins #humanfactorsmd #hfmd #testingforlife

Reach out to learn more about how our dedicated team here at Matica Biotechnology, Inc. can help meet your virally modified cell therapy or gene therapy preclinical production and cGMP clinical manufacturing needs! We have put together very creative options around financing strategies to support the unique needs of early stage developers (pre-clinical and early stage clinical) through these currently difficult times in the market. Just ping me to learn more! #viralvector #genetherapy #celltherapy #cGMP #ProcessDevelopment

Teddy JÉGU, our Director of Research, will be speaking at the Next Generation Therapy Vector Summit, being held in Boston from June 12-14.   This is the only industry-focused event covering the latest advances and innovations in vector development for gene therapies.   Teddy will be discussing EG 427’s unique technology, focusing on three main points: the characteristics of our non-replicative HSV-1 vector platform; its applications in the peripheral nervous system, such as EG 110A in neurogenic detrusor overactivity (NDO); and its applications in the central nervous system. The talk will take place on June 14 at 2:15pm.   Our solution provides, potential for long-term expression and high safety profile. The high neurotropism and natural retrograde transport of our vectors make them targeted DNA delivery cargos to the nervous system.   Please get in touch if you’d like to schedule a meeting at the event. https://lnkd.in/ezpHs5EQ   #genetherapy #biotech #drugdevelopment

It's day【2】here at analytica! If you haven't had the chance yet to meet us in person, please stop by at booth 109B in hall A3. Ulrich Rant, Ralf Strasser, Stephan Wehselau, Alice Soldà, and Vivien Hafner are here, ready to share insights about our groundbreaking technologies with you. Whether you're curious about #switchSENSE, a unique platform technology for the analysis of molecule-molecule interactions or Real-time Interaction Cytometry #RTIC, a groundbreaking technology enabling the real-time measurement of molecules binding to membrane targets on #cells, we´ve got you covered! 👩🔬 Our mission is to drive innovation in #DrugDiscovery, #lifescience research, and cell & gene therapies, and we'd love to discuss how our solutions can contribute to your projects. 🔬 We look forward to seeing you! 👋 #analytica2024 #biotechnology

Ginkgo Bioworks & bit.bio's alliance is redefining biotech! Their collaboration on cell programming may revolutionize healthcare, mirroring CRISPR's impact on gene therapy. I'm inspired by their ethical innovation and how academia can translate into transformative healthcare solutions. Let's discuss how such partnerships can shape our future! #BiotechInnovation #Healthcare #Collaboration What are your thoughts on the potential of such strategic alliances in biotech? Join the conversation below. Original article: https://lnkd.in/gX43gwXa

Maximising Efficiency in Small Labs: BPES's Tailored Bioprocessing Solutions. At BPES, we're in the business of making big things happen in small spaces. We know that the cell and gene therapy innovations of tomorrow start in the compact labs of today. That's why we've handpicked bioprocessing solutions that fit just right in your lab, ensuring you don't have to compromise on efficiency due to space limitations. From benchtop bioreactors to space-saving purification systems, your ground breaking work deserves the best-fit technology. #SmallLabs #CellAndGeneTherapy #BioprocessingInnovation

Do not miss Vincenzo Di Cerbo, Lead Scientist at the Cell and Gene Therapy Catapult, at ISCT, International Society for Cell & Gene Therapy's 30th Annual Meeting in #Vancouver! Vincenzo will be chairing the roundtable "Enabling Patient Access: Identifying Disruptive Technologies in CGT" on 30th May discussing underdeveloped technological areas, and recognising if trends in technology investments match high-potential areas. Learn more: https://buff.ly/3vPGTSr #AdvancedTherapies #PatientAccess #CellTherapies

🚀 Dive into our newest case study where we follow the journey from Mapping your DNA to unlocking identity, strategy, and success. Explore how we partnered with a newly acquired translational services team to solve their challenge of brand identity, the outcomes that resulted from Mapping their DNA, the costs of neglecting strategic planning, and the keys needed to achieve success in marketing within the Cell and Gene Therapy industry. Read the full case study here: https://lnkd.in/gGnTzegc #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #MappingYourDNA